Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Matrixx Banks On Oral Cold Remedies And A Severe Flu Season

This article was originally published in The Tan Sheet

Executive Summary

Migrating customers to oral forms of its Zicam cold remedies is more critical for Matrixx Initiatives now that FDA refused to reverse its order to pull from the market the intranasal version of the zinc-containing cold products

You may also be interested in...



To Rebuild Zicam, Matrixx Can Tap Into Brand's History, Pharmacists' Regard

Matrixx Initiatives' best chances for rebuilding the Zicam brand appear to be reminding consumers why they initially chose the firm's products and tapping pharmacists' insight on the efficacy of zinc-containing cold remedies

To Rebuild Zicam, Matrixx Can Tap Into Brand's History, Pharmacists' Regard

Matrixx Initiatives' best chances for rebuilding the Zicam brand appear to be reminding consumers why they initially chose the firm's products and tapping pharmacists' insight on the efficacy of zinc-containing cold remedies

To Rebuild Zicam, Matrixx Can Tap Into Brand's History, Pharmacists' Regard

Matrixx Initiatives' best chances for rebuilding the Zicam brand appear to be reminding consumers why they initially chose the firm's products and tapping pharmacists' insight on the efficacy of zinc-containing cold remedies

Related Content

Topics

UsernamePublicRestriction

Register

PS103482

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel